LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer

Clinical trial NCT02612194 · TERMINATED

Trial details

NCT number: NCT02612194
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Ureteral Neoplasms Urethral Neoplasms

Start date: 2016-09-27
Primary completion: 2019-09-17
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.